- Home
- SNT vs COYA Comparison
SNT vs COYA Comparison
Compare SNT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- COYA
- Stock Information
- Founded
- SNT 1965
- COYA 2020
- Country
- SNT Canada
- COYA United States
- Employees
- SNT N/A
- COYA N/A
- Industry
- SNT Telecommunications Equipment
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- SNT Telecommunications
- COYA Health Care
- Exchange
- SNT Nasdaq
- COYA Nasdaq
- Market Cap
- SNT 95.2M
- COYA 107.0M
- IPO Year
- SNT 1993
- COYA 2022
- Fundamental
- Price
- SNT $4.25
- COYA $5.41
- Analyst Decision
- SNT
- COYA Strong Buy
- Analyst Count
- SNT 0
- COYA 4
- Target Price
- SNT N/A
- COYA $16.50
- AVG Volume (30 Days)
- SNT 56.6K
- COYA 116.6K
- Earning Date
- SNT 11-11-2025
- COYA 11-05-2025
- Dividend Yield
- SNT N/A
- COYA N/A
- EPS Growth
- SNT N/A
- COYA N/A
- EPS
- SNT 0.22
- COYA N/A
- Revenue
- SNT $38,038,000.00
- COYA $423,452.00
- Revenue This Year
- SNT N/A
- COYA $40.80
- Revenue Next Year
- SNT N/A
- COYA N/A
- P/E Ratio
- SNT $19.96
- COYA N/A
- Revenue Growth
- SNT 12.79
- COYA N/A
- 52 Week Low
- SNT $1.40
- COYA $4.65
- 52 Week High
- SNT $5.04
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- SNT 43.70
- COYA 33.34
- Support Level
- SNT $4.42
- COYA $5.37
- Resistance Level
- SNT $4.74
- COYA $6.53
- Average True Range (ATR)
- SNT 0.21
- COYA 0.43
- MACD
- SNT -0.01
- COYA -0.12
- Stochastic Oscillator
- SNT 5.77
- COYA 2.65
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.